SCHEMBL17675708

SCHEMBL17675708

CN(Cc1ccc2c(c1)C(Cc1ccccc1)NCCC2)S(=O)(=O)c1cn(C)cn1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
SLC6A9 P48067 6/20 0.47
KCNH2 Q12809 1/20 0.41
HTR2C P28335 1/20 0.38
SLC22A1 O15245 1/20 0.38
PRCP P42785 1/20 0.38
FNTA P49354 2/20 0.37
FNTB P49356 2/20 0.37
PGGT1B P53609 1/20 0.37
ADRB2 P07550 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17675709 0.91 SLC6A9 (0.47) MEN1KMT2ASLC6A9KCNH2SLC22A1
SCHEMBL13827329 0.84 SLC6A9 (0.67) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL13737074 0.77 SLC6A9 (0.69) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL13827337 0.76 SLC6A9 (0.57) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL13827792 0.76 SLC6A9 (0.57) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL17675751 0.76 SLC6A9 (0.56) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL15133291 0.75 KMT2A (1.00) MEN1KMT2ASLC6A9FNTAFNTB
SCHEMBL13827334 0.74 SLC6A9 (0.51) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL13738539 0.73 SLC6A9 (0.64) MEN1KMT2ASLC6A9KCNH2LMNA
SCHEMBL17675759 0.72 SLC6A9 (0.53) MEN1KMT2ASLC6A9KCNH2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309200-B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-04-12 US disclosed
US-9309200-B2 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy AbbVie Deutschland GmbH & Co. KG (DE) 2016-04-12 US disclosed